Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07374107 · ClinicalTrials.gov registry record
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
A clinical trial of Dermatomyositis and Inclusion Body Myositis, sponsored by Myositis International Health & Research Collaborative Alliance Foundation.
- Recruiting
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT07374107 is a study of Dermatomyositis and Inclusion Body Myositis that is actively recruiting participants, run by Myositis International Health & Research Collaborative Alliance Foundation. The registered enrollment target is 700 participants, above the 448-participant average among 19 other Dermatomyositis trials with a reported enrollment target (56% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07374107, a study of Dermatomyositis and Inclusion Body Myositis, is actively recruiting participants, sponsored by Myositis International Health & Research Collaborative Alliance Foundation.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing research concerns as identified by patients. Findings will be analyzed to create a patient-voiced set of research priorities that can guide the direction of research and help inform funding decisions across myositis diseases. Potential participants can express interest via https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/
Conditions Studied
Interventions
- OTHER No intervention - qualitative and mixed methods investigations
Study Locations (1)
Louisiana
- MIHRA Foundation - This is a GLOBAL STUDY - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07374107
The ClinicalTrials.gov registry entry for NCT07374107 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 448-participant average among 19 other Dermatomyositis trials with a reported enrollment target (56% higher). The listed sponsor is Myositis International Health & Research Collaborative Alliance Foundation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Dermatomyositis appearing as the primary indexed condition, and to 1 intervention - of which No intervention - qualitative and mixed methods investigations is the first listed.
NCT07374107 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT07374107 about?
NCT07374107 is a clinical study titled "MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)". Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly...
What is the current status of trial NCT07374107?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2025-06-25. Estimated completion is 2030-12.
What conditions does trial NCT07374107 study?
This clinical trial studies the following conditions: Dermatomyositis, Inclusion Body Myositis, Polymyositis, Myositis, Immune-Mediated Necrotizing Myopathy.
What interventions are being tested in trial NCT07374107?
The interventions under investigation include: No intervention - qualitative and mixed methods investigations (OTHER).
Who is sponsoring clinical trial NCT07374107?
This trial is sponsored by Myositis International Health & Research Collaborative Alliance Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07374107 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatomyositis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
RECRUITING · Phase 3
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
RECRUITING
-
Adult and Juvenile Myositis
RECRUITING
-
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RECRUITING · Phase 2
-
Rheumatology Patient Registry and Biorepository
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.